While Ozempic (semaglutide) is a potent medication for controlling type 2 diabetes, it is not intended for weight loss
doi: 10.1111/dom.12849 32 SimRChongCWLoganadanNKFongAYYNavaravongLHusseinZet al
Myers, S.P
Retatrutide is best suited for patients with significant obesity (BMI 35), severe metabolic resistance, conditions such as type 2 diabetes, metabolic syndrome, or NAFLD, or those who have tried semaglutide or tirzepatide without adequate results and need the most advanced pharmacological metabolic support available as a non-surgical option
Int J Neurosci Khvatova EM et al
Insurance plans from UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, Medicare Part D, and Medicaid often cover weight loss treatments under documented medical need